
    
      Pharmacokinetic and pharmacodynamics studies were performed in parallel with PB-119
      25μg、50μg、and 100μg dose escalation tolerability study, plasma samples were collected to
      determine drug concentration and pharmacodynamics parameters. The study duration of each arm
      was 8 weeks, study medication was given about 8:00 a.m. on day 1 of each week, totally 6
      times, and subject was followed until 15 days after last dose (50 days of study) and then
      study can be completed.
    
  